Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation

J Immunol. 2004 Mar 15;172(6):3553-63. doi: 10.4049/jimmunol.172.6.3553.

Abstract

Heme oxygenase-1 (HO-1) cleaves the porphyrin ring of heme into carbon monoxide, Fe2+, and biliverdin, which is then converted into bilirubin. Heme-derived Fe2+ induces the expression of the iron-sequestering protein ferritin and activates the ATPase Fe2+-secreting pump, which decrease intracellular free Fe2+ content. Based on the antioxidant effect of bilirubin and that of decreased free cellular Fe2+, we questioned whether HO-1 would modulate the expression of proinflammatory genes associated with endothelial cell (EC) activation. We tested this hypothesis specifically for the genes E-selectin (CD62), ICAM-1 (CD54), and VCAM-1 (CD106). We found that HO-1 overexpression in EC inhibited TNF-alpha-mediated E-selectin and VCAM-1, but not ICAM-1 expression, as tested at the RNA and protein level. Heme-driven HO-1 expression had similar effects to those of overexpressed HO-1. In addition, HO-1 inhibited the activation of NF-kappaB, a transcription factor required for TNF-alpha-mediated up-regulation of these genes in EC. Bilirubin and/or Fe2+ chelation mimicked the effects of HO-1, whereas biliverdin or carbon monoxide did not. In conclusion, HO-1 inhibits the expression of proinflammatory genes associated with EC activation via a mechanism that is associated with the inhibition of NF-kappaB activation. This effect of HO-1 is mediated by bilirubin and/or by a decrease of free intracellular Fe2+ but probably not by biliverdin or carbon monoxide.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Bilirubin / pharmacology
  • Carbon Monoxide / pharmacology
  • Cattle
  • Cell Adhesion Molecules
  • Cells, Cultured
  • Down-Regulation / drug effects
  • Down-Regulation / immunology
  • E-Selectin / biosynthesis
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / enzymology*
  • Endothelium, Vascular / immunology*
  • Endothelium, Vascular / metabolism
  • Heme / pharmacology
  • Heme Oxygenase (Decyclizing) / biosynthesis
  • Heme Oxygenase (Decyclizing) / genetics
  • Heme Oxygenase (Decyclizing) / physiology*
  • Heme Oxygenase-1
  • Humans
  • Intercellular Adhesion Molecule-1 / biosynthesis
  • Iron Chelating Agents / pharmacology
  • MAP Kinase Signaling System / immunology
  • Membrane Proteins
  • Mitogen-Activated Protein Kinases / metabolism
  • Mitogen-Activated Protein Kinases / physiology
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / pharmacology
  • Swine
  • Transduction, Genetic
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / physiology
  • Up-Regulation / immunology
  • Vascular Cell Adhesion Molecule-1 / biosynthesis
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Cell Adhesion Molecules
  • E-Selectin
  • Iron Chelating Agents
  • Membrane Proteins
  • NF-kappa B
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • Intercellular Adhesion Molecule-1
  • Heme
  • Carbon Monoxide
  • HMOX1 protein, human
  • Heme Oxygenase (Decyclizing)
  • Heme Oxygenase-1
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Bilirubin